Annual Net Income
-$10.28 M
-$122.28 M-109.18%
31 December 2023
Summary:
TherapeuticsMD annual net profit is currently -$10.28 million, with the most recent change of -$122.28 million (-109.18%) on 31 December 2023. During the last 3 years, it has risen by +$173.25 million (+94.40%). TXMD annual net income is now -109.18% below its all-time high of $112.00 million, reached on 31 December 2022.TXMD Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$609.00 K
+$481.00 K+44.13%
30 September 2024
Summary:
TherapeuticsMD quarterly net profit is currently -$609.00 thousand, with the most recent change of +$481.00 thousand (+44.13%) on 30 September 2024. Over the past year, it has increased by +$2.77 million (+81.97%). TXMD quarterly net income is now -100.54% below its all-time high of $112.28 million, reached on 30 June 2022.TXMD Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$3.32 M
+$2.77 M+45.51%
30 September 2024
Summary:
TherapeuticsMD TTM net profit is currently -$3.32 million, with the most recent change of +$2.77 million (+45.51%) on 30 September 2024. Over the past year, it has dropped by -$71.62 million (-104.85%). TXMD TTM net income is now -102.11% below its all-time high of $157.41 million, reached on 31 March 2023.TXMD TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -109.2% | +82.0% | -104.8% |
3 y3 years | +94.4% | +98.7% | +98.1% |
5 y5 years | +92.3% | +98.1% | +98.0% |
TXMD Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -109.2% | +94.4% | -100.5% | +98.8% | -102.1% | +98.2% |
5 y | 5 years | -109.2% | +94.4% | -100.5% | +98.9% | -102.1% | +98.3% |
alltime | all time | -109.2% | +94.4% | -100.5% | +98.9% | -102.1% | +98.3% |
TherapeuticsMD Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$609.00 K(-44.1%) | -$3.32 M(-45.5%) |
June 2024 | - | -$1.09 M(+48.5%) | -$6.08 M(-17.9%) |
Mar 2024 | - | -$734.00 K(-16.9%) | -$7.41 M(-27.9%) |
Dec 2023 | -$10.28 M(-109.2%) | -$883.00 K(-73.9%) | -$10.28 M(-115.0%) |
Sept 2023 | - | -$3.38 M(+39.9%) | $68.31 M(+59.9%) |
June 2023 | - | -$2.41 M(-33.0%) | $42.72 M(-72.9%) |
Mar 2023 | - | -$3.60 M(-104.6%) | $157.41 M(+40.6%) |
Dec 2022 | $112.00 M(-165.0%) | $77.70 M(-368.3%) | $112.00 M(-1392.5%) |
Sept 2022 | - | -$28.96 M(-125.8%) | -$8.66 M(-68.0%) |
June 2022 | - | $112.28 M(-329.0%) | -$27.12 M(-85.1%) |
Mar 2022 | - | -$49.02 M(+14.1%) | -$182.05 M(+5.6%) |
Dec 2021 | -$172.41 M(-6.1%) | -$42.96 M(-9.4%) | -$172.41 M(+0.5%) |
Sept 2021 | - | -$47.42 M(+11.2%) | -$171.54 M(+9.4%) |
June 2021 | - | -$42.65 M(+8.3%) | -$156.73 M(-5.6%) |
Mar 2021 | - | -$39.38 M(-6.4%) | -$166.06 M(-9.5%) |
Dec 2020 | -$183.52 M(+4.2%) | -$42.09 M(+29.1%) | -$183.52 M(-3.8%) |
Sept 2020 | - | -$32.61 M(-37.3%) | -$190.87 M(+0.3%) |
June 2020 | - | -$51.98 M(-8.6%) | -$190.23 M(-1.7%) |
Mar 2020 | - | -$56.85 M(+15.0%) | -$193.49 M(+9.8%) |
Dec 2019 | -$176.15 M(+32.8%) | -$49.44 M(+54.6%) | -$176.15 M(+6.0%) |
Sept 2019 | - | -$31.97 M(-42.1%) | -$166.10 M(-2.1%) |
June 2019 | - | -$55.24 M(+39.8%) | -$169.74 M(+14.9%) |
Mar 2019 | - | -$39.51 M(+0.3%) | -$147.72 M(+11.4%) |
Dec 2018 | -$132.62 M(+72.4%) | -$39.39 M(+10.6%) | -$132.62 M(+15.7%) |
Sept 2018 | - | -$35.61 M(+7.2%) | -$114.65 M(+22.3%) |
June 2018 | - | -$33.22 M(+36.1%) | -$93.71 M(+16.9%) |
Mar 2018 | - | -$24.40 M(+13.9%) | -$80.17 M(+4.2%) |
Dec 2017 | -$76.93 M(-14.4%) | -$21.43 M(+46.1%) | -$76.93 M(-1.8%) |
Sept 2017 | - | -$14.66 M(-25.5%) | -$78.33 M(-11.7%) |
June 2017 | - | -$19.68 M(-7.0%) | -$88.69 M(-1.6%) |
Mar 2017 | - | -$21.16 M(-7.4%) | -$90.10 M(+0.3%) |
Dec 2016 | -$89.88 M(+5.6%) | -$22.84 M(-8.7%) | -$89.88 M(+6.3%) |
Sept 2016 | - | -$25.02 M(+18.6%) | -$84.52 M(+7.0%) |
June 2016 | - | -$21.09 M(+0.8%) | -$78.98 M(-7.2%) |
Mar 2016 | - | -$20.93 M(+19.7%) | -$85.11 M(+0.0%) |
Dec 2015 | -$85.08 M(+56.9%) | -$17.48 M(-10.2%) | -$85.08 M(+1.4%) |
Sept 2015 | - | -$19.47 M(-28.5%) | -$83.90 M(+2.0%) |
June 2015 | - | -$27.23 M(+30.3%) | -$82.26 M(+24.8%) |
Mar 2015 | - | -$20.89 M(+28.2%) | -$65.93 M(+21.6%) |
Dec 2014 | -$54.22 M(+90.8%) | -$16.30 M(-8.6%) | -$54.22 M(+17.1%) |
Sept 2014 | - | -$17.83 M(+63.6%) | -$46.29 M(+28.1%) |
June 2014 | - | -$10.90 M(+18.7%) | -$36.13 M(+15.6%) |
Mar 2014 | - | -$9.18 M(+9.6%) | -$31.24 M(+9.9%) |
Dec 2013 | -$28.42 M(-19.1%) | -$8.38 M(+9.2%) | -$28.44 M(+10.3%) |
Sept 2013 | - | -$7.67 M(+27.7%) | -$25.79 M(+15.3%) |
June 2013 | - | -$6.01 M(-5.7%) | -$22.37 M(-20.7%) |
Mar 2013 | - | -$6.38 M(+11.3%) | -$28.21 M(-19.7%) |
Dec 2012 | -$35.12 M(+172.0%) | -$5.73 M(+34.7%) | -$35.12 M(-9.9%) |
Sept 2012 | - | -$4.25 M(-64.1%) | -$38.98 M(+7.6%) |
June 2012 | - | -$11.85 M(-10.8%) | -$36.21 M(+42.4%) |
Mar 2012 | - | -$13.29 M(+38.6%) | -$25.43 M(+96.9%) |
Dec 2011 | -$12.91 M | -$9.59 M(+544.7%) | -$12.91 M(+130.2%) |
Sept 2011 | - | -$1.49 M(+39.4%) | -$5.61 M(+37.1%) |
June 2011 | - | -$1.07 M(+37.7%) | -$4.09 M(+24.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2011 | - | -$774.40 K(-66.0%) | -$3.29 M(+14.9%) |
Dec 2010 | -$2.87 M(+73.3%) | -$2.28 M(-7703.0%) | -$2.87 M(+135.5%) |
Sept 2010 | - | $30.00 K(-111.1%) | -$1.22 M(-30.0%) |
June 2010 | - | -$269.10 K(-22.5%) | -$1.74 M(+17.2%) |
Mar 2010 | - | -$347.40 K(-45.0%) | -$1.48 M(+27.3%) |
Dec 2009 | -$1.65 M(+318.2%) | -$631.30 K(+28.5%) | -$1.17 M(+113.4%) |
Sept 2009 | - | -$491.30 K(+3359.9%) | -$546.40 K(+437.8%) |
June 2009 | - | -$14.20 K(-51.0%) | -$101.60 K(-74.1%) |
Mar 2009 | - | -$29.00 K(+143.7%) | -$391.90 K(-0.9%) |
Dec 2008 | -$395.60 K(-332.0%) | -$11.90 K(-74.4%) | -$395.60 K(-7.1%) |
Sept 2008 | - | -$46.50 K(-84.7%) | -$425.90 K(+48.7%) |
June 2008 | - | -$304.50 K(+831.2%) | -$286.50 K(-443.5%) |
Mar 2008 | - | -$32.70 K(-22.5%) | $83.40 K(-51.1%) |
Dec 2007 | $170.50 K(+25.4%) | -$42.20 K(-145.4%) | $170.50 K(+196.5%) |
Sept 2007 | - | $92.90 K(+42.0%) | $57.50 K(-51.6%) |
June 2007 | - | $65.40 K(+20.2%) | $118.80 K(-9.8%) |
Mar 2007 | - | $54.40 K(-135.1%) | $131.70 K(-2.5%) |
Dec 2006 | $136.00 K(-57.9%) | -$155.20 K(-200.6%) | $135.10 K(-67.6%) |
Sept 2006 | - | $154.20 K(+96.9%) | $416.50 K(+11.3%) |
June 2006 | - | $78.30 K(+35.5%) | $374.10 K(+22.6%) |
Mar 2006 | - | $57.80 K(-54.2%) | $305.20 K(-5.7%) |
Dec 2005 | $323.40 K(+127.6%) | $126.20 K(+12.9%) | $323.60 K(+14.9%) |
Sept 2005 | - | $111.80 K(+1089.4%) | $281.70 K(+25.4%) |
June 2005 | - | $9400.00(-87.7%) | $224.70 K(-7.5%) |
Mar 2005 | - | $76.20 K(-9.6%) | $243.00 K(+71.0%) |
Dec 2004 | $142.10 K(+51.0%) | $84.30 K(+53.8%) | $142.10 K(+64.7%) |
Sept 2004 | - | $54.80 K(+97.8%) | $86.30 K(+17.1%) |
June 2004 | - | $27.70 K(-212.1%) | $73.70 K(+26.4%) |
Mar 2004 | - | -$24.70 K(-186.7%) | $58.30 K(-38.0%) |
Dec 2003 | $94.10 K(-4.9%) | $28.50 K(-32.5%) | $94.10 K(-7.5%) |
Sept 2003 | - | $42.20 K(+243.1%) | $101.70 K(+22.7%) |
June 2003 | - | $12.30 K(+10.8%) | $82.90 K(-4.9%) |
Mar 2003 | - | $11.10 K(-69.3%) | $87.20 K(-11.8%) |
Dec 2002 | $98.90 K(+60.8%) | $36.10 K(+54.3%) | $98.90 K(+144.8%) |
Sept 2002 | - | $23.40 K(+41.0%) | $40.40 K(+36.5%) |
June 2002 | - | $16.60 K(-27.2%) | $29.60 K(-34.2%) |
Mar 2002 | - | $22.80 K(-201.8%) | $45.00 K(-26.8%) |
Dec 2001 | $61.50 K(+94.0%) | -$22.40 K(-277.8%) | $61.50 K(+16.3%) |
Sept 2001 | - | $12.60 K(-60.6%) | $52.90 K(-31.3%) |
June 2001 | - | $32.00 K(-18.6%) | $77.00 K(+28.3%) |
Mar 2001 | - | $39.30 K(-226.8%) | $60.00 K(+89.9%) |
Dec 2000 | $31.70 K(+155.6%) | -$31.00 K(-184.5%) | $31.60 K(-48.4%) |
Sept 2000 | - | $36.70 K(+144.7%) | $61.20 K(+68.6%) |
June 2000 | - | $15.00 K(+37.6%) | $36.30 K(+18.2%) |
Mar 2000 | - | $10.90 K(-878.6%) | $30.70 K(+147.6%) |
Dec 1999 | $12.40 K(-179.5%) | -$1400.00(-111.9%) | $12.40 K(-10.1%) |
Sept 1999 | - | $11.80 K(+25.5%) | $13.80 K(+590.0%) |
June 1999 | - | $9400.00(-227.0%) | $2000.00(-127.0%) |
Mar 1999 | - | -$7400.00 | -$7400.00 |
Dec 1998 | -$15.60 K(+22.8%) | - | - |
Dec 1997 | -$12.70 K(-117.2%) | - | - |
Dec 1996 | $73.80 K(+134.3%) | - | - |
Dec 1995 | $31.50 K(-7.9%) | - | - |
Dec 1994 | $34.20 K(-19.7%) | - | - |
Dec 1993 | $42.60 K | - | - |
FAQ
- What is TherapeuticsMD annual net profit?
- What is the all time high annual net income for TherapeuticsMD?
- What is TherapeuticsMD annual net income year-on-year change?
- What is TherapeuticsMD quarterly net profit?
- What is the all time high quarterly net income for TherapeuticsMD?
- What is TherapeuticsMD quarterly net income year-on-year change?
- What is TherapeuticsMD TTM net profit?
- What is the all time high TTM net income for TherapeuticsMD?
- What is TherapeuticsMD TTM net income year-on-year change?
What is TherapeuticsMD annual net profit?
The current annual net income of TXMD is -$10.28 M
What is the all time high annual net income for TherapeuticsMD?
TherapeuticsMD all-time high annual net profit is $112.00 M
What is TherapeuticsMD annual net income year-on-year change?
Over the past year, TXMD annual net profit has changed by -$122.28 M (-109.18%)
What is TherapeuticsMD quarterly net profit?
The current quarterly net income of TXMD is -$609.00 K
What is the all time high quarterly net income for TherapeuticsMD?
TherapeuticsMD all-time high quarterly net profit is $112.28 M
What is TherapeuticsMD quarterly net income year-on-year change?
Over the past year, TXMD quarterly net profit has changed by +$2.77 M (+81.97%)
What is TherapeuticsMD TTM net profit?
The current TTM net income of TXMD is -$3.32 M
What is the all time high TTM net income for TherapeuticsMD?
TherapeuticsMD all-time high TTM net profit is $157.41 M
What is TherapeuticsMD TTM net income year-on-year change?
Over the past year, TXMD TTM net profit has changed by -$71.62 M (-104.85%)